NPS PHARMACEUTICALS, INC.

Inactive Instrument

Insiders NPS Pharmaceuticals, Inc.

Equities

US62936P1030

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2015	NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval	RE
2015	NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase	RE

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NPS Pharmaceuticals, Inc. : NPS Pharmaceuticals Named One of New Jersey's 50 Fastest Growing Companies by NJBIZ	13-11-20	BU
NPS Pharmaceuticals, Inc. : Dr. Francois Nader, President and CEO of NPS Pharmaceuticals, Appointed to Biotechnology Industry Organization’s Board of Directors	13-09-10	PU
NPS Pharmaceuticals, Inc. : Dr. Francois Nader, President and CEO of NPS Pharmaceuticals, Appointed to Biotechnology Industry Organization's Board of Directors	13-09-10	BU
NPS PARMTCL : NPS Pharmaceuticals CFO Luke Beshar Named New Jersey Public Company CFO of the Year by NJBIZ	10-11-04	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer